Jibin Yang

Title: Jibin Yang: Innovator in Pharmaceutical Research

Introduction

Jibin Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of 2 patents, Yang's work is paving the way for innovative treatments.

Latest Patents

Yang's latest patents focus on iso-citrate dehydrogenase (IDH) inhibitors. These patents disclose compounds that inhibit the conversion of α-KG to D-2-HG, along with pharmaceutically acceptable salts, hydrates, solvates, or stereoisomers thereof. The pharmaceutical compositions comprising these compounds can effectively treat IDH-associated diseases, including cancer. This groundbreaking work highlights Yang's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Jibin Yang has worked with notable companies such as Shanghai Meton Pharmaceutical Co., Ltd and Zhejiang Meton Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovation and research.

Collaborations

Yang has collaborated with esteemed colleagues, including Feng Yan and Jinlong Zhu. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Jibin Yang's contributions to pharmaceutical research and his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to inspire advancements in the treatment of serious diseases.